Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cilastatin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Patent CN102675175B reveals an electrodialysis method for cilastatin purification, offering high purity, low ignition residue, and scalable manufacturing for pharmaceutical intermediates.
Patent CN102161978B reveals a green Rhodococcus strain for Cilastatin intermediates. Achieve high optical purity with reduced environmental impact and lower manufacturing costs.
Patent CN101386588B reveals a low-temperature isomerization method for high-purity cilastatin acid intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN104193645A reveals efficient asymmetric synthesis. Delivers >99.5% ee. Ideal for Cilastatin production. Cost-effective supply chain solution for global buyers.
Advanced purification technology for Cilastatin Sodium intermediate ensuring high purity and supply chain reliability for global pharmaceutical manufacturers seeking cost-effective solutions.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.